Apply for Funding

CPRIT offers several funding opportunities for promising cancer research, product development, and prevention programs. All funding opportunities are announced through formal Requests for Applications (RFAs) and applications must be submitted through the online application receipt system.

Learn more about the grants process.

Evidence-Based Cancer Prevention Services

Program Prevention
RFA Status Open
Description

This award mechanism seeks to fund projects that will deliver evidence-based cancer prevention and control clinical services. Priority will be given to projects that propose to address CPRIT areas of emphasis and serve areas of the state not well addressed by current CPRIT funded projects. Only proposals for new projects or expansion of currently/previously funded projects focused on obesity control/healthy living or survivor care are eligible under this mechanism. Eligible applications must include the delivery of services to nonmetropolitan (rural) and medically underserved counties in the state.

Award: Maximum of $1M; Maximum duration of 36 months.

A webinar will be held on June 16, 2021 regarding this RFA. Register Now!

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release May 07, 2021
Application Receipt June 03, 2021 - September 01, 2021
Application Review September 2021 - January 2022
Award Notification February 2022

Expansion of Cancer Prevention Services to Rural and Medically Underserved Populations

Program Prevention
RFA Status Open
Description

This award mechanism seeks to support the coordination and expansion of evidence based services to prevent cancer in underserved populations who do not have adequate access to cancer prevention interventions and health care, bringing together networks of public health and community partners to carry out programs tailored for their communities. Projects should identify cancers that cause the most burden in the community and use evidence-based models shown to work in similar communities to prevent and control these cancers. For the first expansion application, eligible applicants should propose to expand their programs to include additional types of prevention clinical services and/or an expansion of current clinical services into additional counties. For a subsequent expansion, additional clinical services and/or expansion to additional counties is optional; the number of clinical services delivered must be increased substantially if no further geographic or clinical service expansion is proposed.

Initial Expansion: up to $2M over 36 months

Maintenance Expansion: up to $2.5M over 60 months

A webinar will be held on June 16, 2021 regarding this RFA. Register Now!

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release May 07, 2021
Application Receipt June 03, 2021 - September 01, 2021
Application Review September 2021 - January 2022
Award Notification February 2022

Prevention Program Assessment

Program Prevention
RFA Status Open
Description

This award mechanism solicits applications for one project to assess the initial progress of the CPRIT Prevention Program since 2010 and to develop an assessment plan for the next stage of the CPRIT Prevention Program. The evaluation will use a mixed-methods approach, which combines quantitative and qualitative data to provide evidence of effectiveness and information about how CPRIT-related changes are embedded and sustained in organizations and populations. Evaluation findings will be used to improve program effectiveness and to inform decisions about future program development.

Award: Maximum of $750,000; Maximum duration of 24 months.

A webinar will be held on June 18, 2021 regarding this RFA. Register Now!

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release May 07, 2021
Application Receipt June 03, 2021 - September 01, 2021
Application Review September 2021 - January 2022
Award Notification February 2022

Tobacco Control and Lung Cancer Screening

Program Prevention
RFA Status Open
Description

This award mechanism seeks to fund programs on tobacco prevention and cessation, as well as screening for early detection of lung cancer. Through release of this RFA, CPRIT’s goal is to stimulate more programs across the state, thereby providing greater access for underserved populations and reducing the incidence and mortality rates of tobacco-related cancers. This RFA seeks to promote and deliver evidence-based programming designed to significantly increase tobacco cessation among adults and/or prevent tobacco use by youth.

Award: Maximum of $1 M; Maximum duration of 36 months

A webinar will be held on June 16, 2021 regarding this RFA. Register Now!

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release May 07, 2021
Application Receipt June 03, 2021 - September 01, 2021
Application Review September 2021 - January 2022
Award Notification February 2022

Individual Investigator Research Awards

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications for innovative research projects addressing critically important questions that will significantly advance knowledge of the causes, prevention, and/or treatment of cancer. Areas of interest include laboratory research, translational studies, and/or clinical investigations. Competitive renewal applications accepted.

Award: Up to $350,000 per year. Exceptions permitted if extremely well justified; maximum duration: 3 years.

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release January 13, 2021
Application Receipt March 03, 2021 - June 02, 2021
Application Review June 2021 - February 2022
Award Notification February 2022

Individual Investigator Research Awards for Cancer in Children and Adolescents

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications for innovative research projects addressing questions that will advance knowledge of the causes, prevention, progression, detection, or treatment of cancer in children and adolescents. Laboratory, clinical, or population-based studies are all acceptable. CPRIT expects the outcome of the research to reduce the incidence, morbidity, or mortality from cancer in children and/or adolescents in the near or long term. Competitive renewal applications accepted.

Award: Up to $350,000 per year. Applicants that plan on conducting a clinical trial as part of the project may request up to $500,000 in total costs. Exceptions permitted if extremely well justified; maximum duration: 4 years.

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release January 13, 2021
Application Receipt March 03, 2021 - June 02, 2021
Application Review June 2021 - February 2022
Award Notification February 2022

Individual Investigator Research Awards for Clinical Translation

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications that propose innovative cancer clinical studies that are hypothesis driven and involve patients enrolled prospectively on a clinical trial. Areas of interest include clinical studies of new or repurposed drugs, hormonal therapies, immune therapies, surgery, radiation therapy, stem cell transplantation, combinations of interventions, or therapeutic devices.

Award: Up to $500,000 per year. Maximum duration: 4 years.   Exceptions permitted if extremely well justified.

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release January 13, 2021
Application Receipt March 03, 2021 - June 02, 2021
Application Review June 2021 - February 2022
Award Notification February 2022

Individual Investigator Research Awards for Computational Systems Biology of Cancer

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications for innovative mathematical and/or computational research projects addressing questions that will advance current knowledge in the (a) mechanisms that tie altered gene expression and downstream molecular mechanisms to functional cancer phenotypes and/or (b) mechanisms that tie tumor morphology to functional cancer phenotypes and/or mechanisms that tie treatment sequence and combination to evolving functional cancer phenotypes (that emerge as a result of treatment selection).

Award: Up to $400,000 in total costs per year for up to 3 years. Exceptions permitted if extremely well justified.

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release January 13, 2021
Application Receipt March 03, 2021 - June 02, 2021
Application Review June 2021 - February 2022
Award Notification February 2022

Individual Investigator Research Awards for Prevention and Early Detection

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications which propose clinical and population-based projects designed to develop effective prevention and early detection interventions to reduce cancer risk, mortality, and morbidity among Texans. Projects that propose such research collaborations with existing CPRIT Prevention Program awardees including the CPRIT funded Texas Collaborative Center for Hepatocellular Cancer (https://www.bcm.edu/research/labs-and-centers/research-centers/texas-collaborative-center-for-hepatocellular-cancer) are strongly encouraged. 

Award: Up to $500,000 per year. Exceptions permitted if extremely well justified; maximum duration: 4 years.

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release January 13, 2021
Application Receipt March 03, 2021 - June 02, 2021
Application Review June 2021 - February 2022
Award Notification February 2022

Recruitment of Established Investigators

Revised: 10/26/2020

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Recruits outstanding senior research faculty with distinguished professional careers and established cancer research programs to academic institutions in Texas.

Award: Up to $6 million over a period of five years.

Review Cycle Fiscal Year 2021 - Cycle 1
RFA Release June 23, 2020
Application Receipt June 23, 2020 - June 21, 2021
Application Review Continuous
Award Notification Continuous

Recruitment of First-Time, Tenure-Track Faculty Members

Revised: 09/24/2020

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports very promising emerging investigators, pursuing their first faculty appointment in Texas, who have the ability to make outstanding contributions to the field of cancer research.

Award: Up to $2 million up to a period of five years.

Review Cycle Fiscal Year 2021 - Cycle 1
RFA Release June 23, 2020
Application Receipt June 23, 2020 - June 21, 2021
Application Review Continuous
Award Notification Continuous

Recruitment of Rising Stars

Revised: 10/26/2020

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Recruits outstanding early-stage investigators to Texas, who have demonstrated the promise for continued and enhanced contributions to the field of cancer research.

Award: Up to $4 million over a period of five years.

Review Cycle Fiscal Year 2021 - Cycle 1
RFA Release June 23, 2020
Application Receipt June 23, 2020 - June 21, 2021
Application Review Continuous
Award Notification Continuous